Japanese Ministry of Health Approves Pfizer's COVID Vaccine for Children
Pfizer Inc. in Japan has received approval for two versions of the COVID-19 vaccine. One version is targeted at children six months of age and older. The second version is targeted to protect against Omicron's BA.4 and BA.5 subvariants. The approval was recommended by the Department of Health on Wednesday.
Recommended
Energy and Precious Metals Market events for February 2-3, 2023
2 February 2023
Last year recorded an increased demand for gold up to the levels of 2011
1 February 2023
Exxon Mobile is criticized for $56 billion profit
1 February 2023
White House Supports Alaska Oil Project
1 February 2023
Aluminum buyers from Japan agreed to pay extra charges in the first quarter
1 February 2023
Top news
Nothing found